Glucocorticoids and the development of agonistic behaviour during puberty in male golden hamsters.
During puberty, the agonistic behaviour of male golden hamsters undergoes a transition from play fighting to adult aggression. Repeated exposure to social stress early in puberty accelerates this transition. The present study investigated the possible role of glucocorticoids on the maturation of agonistic behaviour. First, we compared serum cortisol levels following a 20-min restraint stress during early puberty, mid-puberty or adulthood. Across puberty, animals exhibited a two-fold increase in post-restraint cortisol levels. We also compared corticotrophin-releasing hormone (CRH) immunoreactive fibres projecting to the median eminence between animals in early puberty and adulthood. The CRH fibre density was two-fold greater in adults compared to juveniles. Furthermore, we investigated the effects of stress hormones on the maturation of agonistic behaviour. Male hamsters were injected daily with dexamethasone, a corticosteroid receptor type II agonist (0, 10 or 40 microg/100 g), early in puberty from postnatal day 31 (P-31) to P-36. When paired with a smaller and younger intruder on P-37, attack frequency did not differ between groups. However, dexamethasone-treated animals showed a dose-dependent decrease in the percentage of play-fighting attacks and an increase in the percentage of adult attacks. In summary, puberty can be described as a period of increasing hypothalamic-pituitary-adrenal activity in male golden hamsters. Moreover, increasing glucocorticoid levels influence the maturation of agonistic behaviour. These data shed new light on the neuroendocrine mechanisms that regulate the maturation of social behaviours during puberty.
Wommack
J C
JC
Psychology Department and Institute for Neuroscience, The University of Texas at Austin, Austin, TX 78712, USA. joelwommack@aol.com
Salinas
A
A
Delville
Y
Y
D000374:Aggression / Q000187:drug effects / Q000502:physiology*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism; D006224:Cricetinae; D003907:Dexamethasone / Q000494:pharmacology; D005260:Female; D005938:Glucocorticoids / Q000502:physiology*; D006854:Hydrocortisone / Q000097:blood; D008297:Male; D008647:Mesocricetus; D010286:Paraventricular Hypothalamic Nucleus / Q000378:metabolism; D011987:Receptors, Steroid / Q000378:metabolism; D012149:Restraint, Physical; D012741:Sexual Maturation / Q000187:drug effects / Q000502:physiology*; D013312:Stress, Physiological / Q000503:physiopathology
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D011987:Receptors, Steroid; D003907:Dexamethasone; D003346:Corticotropin-Releasing Hormone; D006854:Hydrocortisone